Solana

Upexi (UPXI) reported FY2025 revenue of $15.8M with a 67% gross margin, but a $13.7M net loss. However, its Solana (SOL) treasury surged to 2,018,419 SOL, a 174% increase. This boosted NAV to $433M, a 281% jump, with unrealized gains of $128M (up 1,300%). Staking generates ~$100K daily revenue at an 8% yield. Upexi has pivoted towards becoming a Solana treasury vehicle.

SRx Health Solutions (NYSE: SRXH) reallocated $1.5 million from Solana (SOL) to Ethereum (ETH), approved by Chairman Adesh Vora to boost treasury diversification and sustainable shareholder value. The move leverages Ethereum’s institutional adoption and perceived stability over Solana’s volatility, reflecting strategic agility. However, crypto market fluctuations and regulatory risks persist, potentially sparking investor concerns about capital exposure in volatile digital assets.